ZBH

#612
Zimmer Biomet Holdings, Inc. Common Stock
99.3 2 USD
0.00%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
99.23
101.81
Intervallo Annuale
79.12
103.69
Variazione giornaliera
-0.19%
Variazione Mensile
+4.00%
Variazione di 6 mesi
+1.40%
Variazione Annuale
-4.04%
Chiusura Precedente
99.5 1
Open
100.1 6
Minimo
99.2 3
Massimo
101.8 1
Volume
248
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Dividendi Documents

2026

Current report, Q3 FY2026
ZIMMER BIOMET HOLDINGS, INC. current report, Q3 FY2026
8-K
Current report, Q3 FY2026
ZIMMER BIOMET HOLDINGS, INC. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
ZIMMER BIOMET HOLDINGS, INC. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
ZIMMER BIOMET HOLDINGS, INC. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
ZIMMER BIOMET HOLDINGS, INC. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
ZIMMER BIOMET HOLDINGS, INC. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
ZIMMER BIOMET HOLDINGS, INC. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
ZIMMER BIOMET HOLDINGS, INC. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
ZIMMER BIOMET HOLDINGS, INC. quarterly report, Q1 FY2026
10-Q
Current report, Q1 FY2026
ZIMMER BIOMET HOLDINGS, INC. current report, Q1 FY2026
8-K

ZIMMER BIOMET HOLDINGS, INC. current report, Q4 FY2003

Full document

Business Context and Reporting Period

Zimmer Holdings, Inc. (now Zimmer Biomet Holdings, Inc.) filed this Form 8-K on October 22, 2003, to report its results of operations for the quarter ended September 30, 2003. The filing incorporates by reference an earnings release attached as Exhibit 99(a).

Key Financial Metrics

The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It references an attached press release (Exhibit 99(a)) containing these details. The document notes that management utilizes non-GAAP measures including Free Cash Flow, EBITDA Margin, Adjusted Operating Profit Margin, and Adjusted Net Earnings Margin, which are reconciled to comparable GAAP measures in the attached exhibit.

Material Changes

The filing text does not disclose specific material changes versus the prior comparable period. It states only that the results of operations for the quarter ended September 30, 2003, are reported in the attached exhibit.

Guidance, Outlook, and Management Commentary

Management commentary within this specific filing text focuses on the utility of non-GAAP financial measures. Management considers Free Cash Flow important for assessing cash available for debt repayment and acquisitions. Additionally, EBITDA Margin, Adjusted Operating Profit Margin, and Adjusted Net Earnings Margin are highlighted as key profitability metrics used by investors and analysts. The filing explicitly states these non-GAAP measures should be viewed in addition to, not as a substitute for, GAAP measures. No specific forward-looking guidance or risk factors are detailed in the text of this 8-K summary.

Investor Verification Checklist

  • Review Exhibit 99(a) (the attached press release) for specific revenue, earnings, and cash flow figures for the quarter ended September 30, 2003.
  • Verify the reconciliation tables between non-GAAP measures (Free Cash Flow, EBITDA Margin) and GAAP measures provided in the attached exhibit.
  • Confirm the specific year-over-year or quarter-over-quarter percentage changes in financial performance, as these are not listed in the 8-K text itself.
  • Check for any specific guidance or outlook statements contained within the attached earnings release.

Notizie